GeneTex
Events
-
Webinar - The interface of the ovary and fallopian tube during ovarian cancer formation and spread
Wednesday, April 5, 2023 at 10:00 a.m. (EDT)
Speaker: Joanna E. Burdette, Ph.D.
Dr. Joanna E. Burdette earned her B.S. from Emory University in Biology and her Ph.D. at the University of Illinois at Chicago. She was a postdoctoral fellow at Northwestern University. She is the Edward and Josephine Chair in Pharmacognosy and Medicinal Chemistry as well as the Associate Dean for Research and Graduate Studies in the College of Pharmacy. She serves as the co-Director for the Cancer Biology Program in the UI Cancer Center and the co-director of the IRACDA program, which focuses on training postdoctoral fellows in research and teaching with an emphasis on diversity and inclusion. Her research has helped to develop three-dimensional models of the fallopian tube epithelium, which is thought to be the source for the deadliest type of ovarian cancer, high grade serous cancer. She has held leadership roles in the Endocrine Society, the Society for the Study of Reproduction, and in the Gynecologic Oncology Group. She has been the recipient of the Liz Tilberis Scholar Award from the Ovarian Cancer Research Fund, the UIC Rising Star, UIC Distinguished Researcher, and University Scholar. -
Webinar - SARS-CoV-2 Omicron therapeutics: Getting to know the unknown and the road ahead
Wednesday, February 22, 2023 at 11:30 a.m. (EST)
Speaker: François Jean, PhD
François Jean, PhD, is an expert in antiviral drug discovery and professor of molecular virology at the University of British Columbia (UBC). He is the founder of the UBC’s Facility for Infectious Disease and Epidemic Research (FINDER), one of the largest university-based containment level 3 (CL-3) facilities in the world. He is currently leading major international research initiatives funded by the Canadian Institutes of Health Research (CIHR) to discover broad-spectrum drugs active against current infections with the circulating SARS-CoV-2 variants and future pandemic-causing viral pathogens. He is the Lead of Pillar 10, Antiviral Strategies & Antiviral Therapeutics, at the Coronavirus Variants Rapid Response Network (CoVaRR-Net). He has won several prestigious scholarly awards including the CIHR New Investigator Salary Award, the UBC Peter Wall Institute for Advanced Studies Early Career Scholar Start-Up Research Grant, the Thermo Fisher Scientific Award from the Canadian Society for Microbiologists, and UBC’s Faculty of Science Excellence in Service Award in recognition of his leadership role in establishing FINDER. His webinar will highlight the exciting and ongoing advances his lab has made in novel SARS-CoV-2 antiviral drug discovery since he last spoke in the GeneTex Webinar Series. -
Webinar - Blood plasma-derived extracellular vesicles: A minimally invasive tool for predicting response to cancer treatment
Tuesday, November 29, 2022 at 10:00 am (EST)
Speaker: Chioma M. Okeoma, Ph.D.
My laboratory investigates how host factors expressed in host cells or present in the extracellular milieu, such as extracellular vesicles and extracellular condensates, regulate response against infective agents and disease pathogenesis. Our translational experiments use primary cells, animal models, and human clinical specimens to study spatiotemporal regulation of host factors and their effects on clinical outcomes. We use integrative scientific approaches including multimodal datasets, computational modeling, Omics technologies, and cellular and molecular biology experimental tools in our studies. Discoveries made through this area of research will expand our knowledge and may lay the foundation for development of new tools and strategies for treatment and prevention of diseases. My laboratory provides an environment that encourages, nurtures, and values diversity, inclusivity, and innovation. My laboratory is funded by multiple active grants. We also have multiple pending grants. -
Webinar - RAS Genes in Development and Cancer
Wednesday, October 5, 2022 at 10:00 am (EDT)
Speaker: Matthias Drosten, Ph.D.
Matthias Drosten studied Biology at the University of Bochum in Germany. He later joined the laboratory of Professor Brigitte Pützer at the University of Essen Medical School (Germany) where he obtained his Ph.D. for his work on the role of the RET oncogene in thyroid cancer. In 2004 he moved to Spain and joined the laboratory of Dr. Mariano Barbacid at the Spanish National Cancer Research Center (CNIO) in Madrid as a postdoctoral fellow to work on RAS signaling and biology. In 2008 he acquired a permanent position as a staff scientist in the same group and expanded his research interests to the role of KRAS in lung cancer with special emphasis on the generation of genetically-engineered mouse models. In 2021 he joined the Cancer Research Center (CIC) in Salamanca (Spain) as a group leader where he continues to focus his research efforts on KRAS signaling and lung cancer.
